New Key Statistics Module, Z-Score and F-Score
GREY:BXMPY Key Ratios
| Market Cap $ M | 316.52 |
| Enterprise Value $ M | 952.81 |
| P/E(ttm) | 9.75 |
| PE Ratio without NRI | 9.75 |
| Forward PE Ratio | 7.81 |
| Price/Book | 0.79 |
| Price/Sales | 1.15 |
| Price/Free Cash Flow | 13.85 |
| Price/Owner Earnings | 31.44 |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | -- |
| EPS (TTM) $ | -- |
| Beneish M-Score | -2.36 |
| 10-y EBITDA Growth Rate % | 15.30 |
| 5-y EBITDA Growth Rate % | 19.60 |
| y-y EBITDA Growth Rate % | -0.20 |
| EV-to-EBIT | 7.51 |
| EV-to-EBITDA | 7.51 |
| PEG | 0.50 |
| Shares Outstanding M | 446.11 |
| Net Margin (%) | 11.83 |
| Operating Margin % | 18.23 |
| Pre-tax Margin (%) | 15.25 |
| Quick Ratio | 0.72 |
| Current Ratio | 1.80 |
| ROA % (ttm) | 5.42 |
| ROE % (ttm) | 8.49 |
| ROIC % (ttm) | 7.05 |
| Dividend Yield % | -- |
| Altman Z-Score | 2.88 |
BXMPY Number of Guru Trades
BXMPY Volume of Guru Trades
Gurus Latest Trades with GREY:BXMPY
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
GREY:BXMPY is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Beximco Pharmaceuticals Ltd Insider Transactions
No Available Data
News about GREY:BXMPY
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers